Alectinib Versus Pemetrexed or Docetaxel in Anaplastic Lymphoma Kinase (ALK)-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) Participants Previously Treated With Platinum-Based Chemotherapy and Crizotinib
Clinical trial NCT02604342 · COMPLETED
Trial details
- NCT number
- NCT02604342
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-03
- Primary completion
- 2017-01-26
- Enrollment
- 119
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.